미국의 호흡용 DME 시장 규모, 점유율, 동향 분석 보고서 : 제품 제공별, 유통 및 서비스 채널별, 주요주별, 부문별 예측(2026-2033년)

U.S. Respiratory Durable Medical Equipment Market Summary

The U.S. respiratory durable medical equipment (DME) market size was valued at USD 4.01 billion in 2025 and is projected to reach USD 5.89 billion by 2033, growing at a CAGR of 4.93% from 2026 to 2033. This growth is attributed to the technological advances smaller, more efficient portable oxygen concentrators, improved non-invasive home ventilators and connected PAP machines.

In addition, higher chronic respiratory disease prevalence (notably COPD and related comorbidities) in many Midwestern states together with an older, Medicare-heavy population and large rural patient cohorts who prefer home-based care, creates enduring demand for concentrators, portable oxygen systems and home ventilators. The Midwest has a comparatively higher prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep-disordered breathing, largely due to an aging population and higher smoking prevalence in certain states.

According to the American Lung Association, in 2023, approximately 11.1 million adults in the United States are living with COPD, which remains a leading cause of morbidity and mortality and is associated with an estimated USD 50 billion in annual healthcare costs. The increasing burden of COPD, combined with the need for non-invasive ventilation to manage hypercapnia, acute exacerbations, and sleep-disordered breathing in these patients, has fueled demand for home and hospital-based BiPAP/VPAP devices.

States such as Ohio, Michigan, Indiana, Illinois, and Missouri report a significant burden of COPD and obstructive sleep apnea (OSA), directly supporting demand for oxygen concentrators, CPAP/BiPAP devices, nebulizers, and ventilatory support equipment. The region's aging demographic profile further accelerates adoption, as older adults are more likely to require long-term respiratory support and post-acute care equipment following hospital discharge.

Moreover, the strong emphasis on home-based care and cost containment across Midwestern healthcare systems, hospitals, and payers is actively shifting respiratory care from inpatient to home settings to reduce length of stay and readmission penalties, increasing reliance on DME providers for long-term oxygen therapy, sleep therapy devices, and remote patient monitoring-enabled respiratory equipment. This trend is fueled by Medicare and Medicaid reimbursement structures, which incentivize home oxygen and sleep therapy utilization, particularly in rural and semi-urban areas that characterize much of the Midwest. In addition, the Midwest has a relatively high proportion of Medicare beneficiaries, making federal reimbursement policies a critical demand driver for respiratory DME volumes.

For instance, Nebraska's payer pattern reflects a mixed urban-rural respiratory profile, where PAP devices tilt toward Medicaid because sleep apnea incidence is higher in the adult, non-elderly population than in the 65+ group. Medicare still contributes substantially but remains secondary as its coverage primarily captures older COPD-dominant cohorts. However, oxygen concentrators, ventilators, and nebulizers lean strongly toward Medicare, consistent with Nebraska's aging COPD and chronic respiratory population that relies more on federal senior coverage. Private plans track smaller shares due to lower employer-sponsored penetration in rural counties.

U.S. Respiratory Durable Medical Equipment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. respiratory durable medical equipment (DME) market report based on product offerings, distribution & service channel, and Midwest states:

• Product Offerings Outlook (Revenue, USD Million, 2021 - 2033)
• Sleep Apnea Devices
  • Auto-titrating CPAP (APAP)
  • Fixed CPAP
  • BiPAP / VPAP
  • Integrated Humidifiers
• Oxygen Therapy
  • Stationary Oxygen Concentrators
  • Portable Oxygen Concentrators (POCs)
  • Cylinders & Regulators
  • Conservers
• Nebulizer Equipment
  • Compressor Nebulizers
  • Mesh Nebulizers
  • Drug-specific nebulizers
• Home & Transport Ventilators
  • Adult/pediatric long-term home ventilators
  • Portable Transport Ventilators
• Masks, Tubing, Filters & Resupply Items (Consumables)
  • CPAP masks
  • CPAP cushions
  • Oxygen tubing & filters
  • Humidifier chambers
  • Bacterial/viral filters
  • Aerosol delivery accessories
• Distribution & Service Channel Outlook (Revenue, USD Million, 2021 - 2033)
• National DME Networks
• Regional Independents
• Hospital/IDN Homecare Extensions
• Online DME Retailers
• Notable States (Midwest Only) Outlook (Revenue, USD Million, 2021 - 2033)
• Nebraska (NE)
• Iowa (IA)
• Kansas (KS)
• South Dakota (SD)
• North Dakota (ND)
• Missouri (MO)
• Minnesota (MN)
• Wisconsin (WI)
• Illinois (IL)
• Colorado (CO)
• Wyoming (WY)
• Ohio (OH)
• Indiana (IN)

Table of Contents

Chapter 1 Research Methodology and Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Regional Scope
  • 1.1.2 Estimates And Forecast Timeline
• 1.2 Objectives
  • 1.2.1 Objective - 1
  • 1.2.2 Objective - 2
  • 1.2.3 Objective - 3
• 1.3 List of Secondary Sources
• 1.4 List of Abbreviation

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Product and End Use Outlook
• 2.3 Competitive Landscape

Chapter 3 U.S. Respiratory Durable Medical Equipment Market: Product Offering Estimates & Trend Analysis

• 3.1 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
• 3.2 Product Offering Movement & Market Share Analysis, 2024 & 2033
• 3.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Product Offering
  • 3.3.1 Sleep Apnea Devices
    • 3.3.1.1 Sleep Apnea Devices Market, 2021 - 2033 (USD Million)
    • 3.3.1.2 Auto-titrating CPAP
    • 3.3.1.3 Fixed CPAP
    • 3.3.1.4 BiPAP/VPAP (S/T, AVAPS)
    • 3.3.1.5 Integrated Humidifiers
  • 3.3.2 Oxygen Therapy
    • 3.3.2.1 Oxygen Therapy Market, 2021 - 2033 (USD Million)
    • 3.3.2.2 Stationary Oxygen Concentrators
    • 3.3.2.3 Portable Oxygen Concentrators (POCs)
    • 3.3.2.4 Cylinders & regulators
    • 3.3.2.5 Conservers
  • 3.3.3 Nebulizer Therapy Equipment
    • 3.3.3.1 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million)
    • 3.3.3.2 Compressor nebulizers
    • 3.3.3.3 Mesh Nebulizers
    • 3.3.3.4 Drug-specific Nebulizers
  • 3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 3.3.4.1 Masks, Tubing, Filters & Resupply Items (Consumables) Market, 2021 - 2033 (USD Million)
    • 3.3.4.2 CPAP Masks & Cushions
    • 3.3.4.3 Oxygen tubing & filters
    • 3.3.4.4 Humidifier Chambers
    • 3.3.4.5 Bacterial/Viral (B/V)
    • 3.3.4.6 Aerosol Delivery Accessories
  • 3.3.5 Home & Transport Ventilators
    • 3.3.5.1 Home & Transport Ventilatorsmarket, 2021 - 2033 (USD Million)
    • 3.3.5.2 Adult/Pediatric Long-Term Home Ventilators
    • 3.3.5.3 Portable Ventilators (Transport/ALS)

Chapter 4 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Estimates & Trend Analysis

• 4.1 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
• 4.2 Distribution & Service Channels Movement & Market Share Analysis, 2024 & 2033
• 4.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Distribution & Service Channels
  • 4.3.1 National Dme Networks
    • 4.3.1.1 National DME Networks market, 2021 - 2033 (USD Million)
  • 4.3.2 Regional Independents
    • 4.3.2.1 Regional Independents Market, 2021 - 2033 (USD Million)
  • 4.3.3 Hospital/Idn Homecare Extensions
    • 4.3.3.1 Hospital/IDN Homecare Extensions Market, 2021 - 2033 (USD Million)
  • 4.3.4 Online Dme Retailers
    • 4.3.4.1 Online DME Retailers Market, 2021 - 2033 (USD Million)

Chapter 5 Regional/State-Level Quantified Deliverables, by Segment, 2021 - 2033, (Revenue, USD Million)

• 5.1 Midwest
  • 5.1.1 Nebraska
    • 5.1.1.1 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.1.2 Demand & Patient Population
      • 5.1.1.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.1.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.1.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.1.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.1.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.1.3 Supplier Density & Network Mapping
    • 5.1.1.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.1.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.1.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.1.5.1 Sleep Clinics
      • 5.1.1.5.2 Pulmonologists
      • 5.1.1.5.3 Hospitals
      • 5.1.1.5.4 Other providers
    • 5.1.1.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.1.7 Research Methodology
  • 5.1.2 IOWA
    • 5.1.2.1 Iowa Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.2.2 Demand & Patient Population
      • 5.1.2.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.2.2.2 Utilization and healthcare service demand metrics, by sleep apnea devices
      • 5.1.2.2.3 Utilization and healthcare service demand metrics, by nebulizers equipment
      • 5.1.2.2.4 Utilization and healthcare service demand metrics, by home & transport ventilators
      • 5.1.2.2.5 Utilization and healthcare service demand metrics, by oxygen therapy
    • 5.1.2.3 Supplier Density & Network Mapping
    • 5.1.2.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.2.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.2.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.2.5.1 Sleep Clinics
      • 5.1.2.5.2 Pulmonologists
      • 5.1.2.5.3 Hospitals
      • 5.1.2.5.4 Other providers
    • 5.1.2.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.2.1 Research Methodology
  • 5.1.3 KANSAS
    • 5.1.3.1 Kansas Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.3.2 Demand & Patient Population
      • 5.1.3.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.3.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.3.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.3.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.3.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.3.3 Supplier Density & Network Mapping
    • 5.1.3.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.3.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.3.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.3.5.1 Sleep Clinics
      • 5.1.3.5.2 Pulmonologists
      • 5.1.3.5.3 Hospitals
      • 5.1.3.5.4 Other providers
    • 5.1.3.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.3.7 Research Methodology
  • 5.1.4 SOUTH DAKOTA
    • 5.1.4.1 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.4.2 Demand & Patient Population
      • 5.1.4.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.4.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.4.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.4.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.4.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.4.3 Supplier Density & Network Mapping
    • 5.1.4.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.4.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.4.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.4.5.1 Sleep Clinics
      • 5.1.4.5.2 Pulmonologists
      • 5.1.4.5.3 Hospitals
      • 5.1.4.5.4 Other providers
    • 5.1.4.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.4.7 Research Methodology
  • 5.1.5 North Dakota
    • 5.1.5.1 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.5.2 Demand & Patient Population
      • 5.1.5.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.5.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.5.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.5.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.5.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.5.3 Supplier Density & Network Mapping
    • 5.1.5.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.5.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.5.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.5.5.1 Sleep Clinics
      • 5.1.5.5.2 Pulmonologists
      • 5.1.5.5.3 Hospitals
      • 5.1.5.5.4 Other providers
    • 5.1.5.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.5.7 Research Methodology
  • 5.1.6 Missouri
    • 5.1.6.1 Missouri Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.6.2 Demand & Patient Population
      • 5.1.6.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.6.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.6.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.6.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.6.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.6.3 Supplier Density & Network Mapping
    • 5.1.6.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.6.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.6.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.6.5.1 Sleep Clinics
      • 5.1.6.5.2 Pulmonologists
      • 5.1.6.5.3 Hospitals
      • 5.1.6.5.4 Other providers
    • 5.1.6.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.6.7 Research Methodology
  • 5.1.7 Minnesota
    • 5.1.7.1 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.7.2 Demand & Patient Population
      • 5.1.7.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.7.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.7.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.7.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.7.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.7.3 Supplier Density & Network Mapping
    • 5.1.7.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.7.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.7.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.7.5.1 Sleep Clinics
      • 5.1.7.5.2 Pulmonologists
      • 5.1.7.5.3 Hospitals
      • 5.1.7.5.4 Other providers
    • 5.1.7.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.7.7 Research Methodology
  • 5.1.8 Wisconsin
    • 5.1.8.1 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.8.2 Demand & Patient Population
      • 5.1.8.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.8.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.8.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.8.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.8.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.8.3 Supplier Density & Network Mapping
    • 5.1.8.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.8.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.8.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.8.5.1 Sleep Clinics
      • 5.1.8.5.2 Pulmonologists
      • 5.1.8.5.3 Hospitals
      • 5.1.8.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.8.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.8.7 Research Methodology
  • 5.1.9 Illinois
    • 5.1.9.1 Illinois Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.9.2 Demand & Patient Population
      • 5.1.9.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.9.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.9.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.9.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.9.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.9.3 Supplier Density & Network Mapping
    • 5.1.9.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.9.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.9.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.9.5.1 Sleep Clinics
      • 5.1.9.5.2 Pulmonologists
      • 5.1.9.5.3 Hospitals
      • 5.1.9.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.9.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.9.7 Research Methodology
  • 5.1.10 Colorado
    • 5.1.10.1 Colorado Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.10.2 Demand & Patient Population
      • 5.1.10.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.10.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.10.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.10.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.10.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.10.3 Supplier Density & Network Mapping
    • 5.1.10.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.10.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.10.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.10.5.1 Sleep Clinics
      • 5.1.10.5.2 Pulmonologists
      • 5.1.10.5.3 Hospitals
      • 5.1.10.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.10.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.10.7 Research Methodology
  • 5.1.11 WYOMING
    • 5.1.11.1 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.11.2 Demand & Patient Population
      • 5.1.11.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.11.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.11.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.11.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.11.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.11.3 Supplier Density & Network Mapping
    • 5.1.11.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.11.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.11.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.11.5.1 Sleep Clinics
      • 5.1.11.5.2 Pulmonologists
      • 5.1.11.5.3 Hospitals
      • 5.1.11.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.11.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.11.7 Research Methodology
  • 5.1.12 OHIO
    • 5.1.12.1 Ohio Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.12.2 Demand & Patient Population
      • 5.1.12.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.12.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.12.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.12.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.12.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.12.3 Supplier Density & Network Mapping
    • 5.1.12.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.12.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.12.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.12.5.1 Sleep Clinics
      • 5.1.12.5.2 Pulmonologists
      • 5.1.12.5.3 Hospitals
      • 5.1.12.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.12.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.12.7 Research Methodology
  • 5.1.13 INDIANA
    • 5.1.13.1 Indiana Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.13.2 Demand & Patient Population
      • 5.1.13.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.13.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.13.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.13.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.13.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.13.3 Supplier Density & Network Mapping
    • 5.1.13.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.13.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.13.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.13.5.1 Sleep Clinics
      • 5.1.13.5.2 Pulmonologists
      • 5.1.13.5.3 Hospitals
      • 5.1.13.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.13.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.13.7 Research Methodology

Chapter 6 Competitive Analysis

• 6.1 Participant's Overview
  • 6.1.1 Tier 1 (National DME Providers)
  • 6.1.2 Tier 2 (OEM Manufacturers)
  • 6.1.3 Tier 3 (Regional Independents)
• 6.2 Financial Performance
  • 6.2.1 Tier 1 (National DME Providers)
    • 6.2.1.1 Public Companies
    • 6.2.1.2 Private Companies
  • 6.2.2 Tier 2 (OEM Manufacturers)
    • 6.2.2.1 Public Companies
    • 6.2.2.2 Private Companies
  • 6.2.3 Tier 3 (Regional Independents)
    • 6.2.3.1 Private Companies
• 6.3 Product Benchmarking
  • 6.3.1 Tier 1 (National DME Providers)
    • 6.3.1.1 Sleep Apnea Devices
    • 6.3.1.2 Oxygen Therapy
      • 6.3.1.2.1 Portable Oxygen Concentrators
      • 6.3.1.2.2 Stationary Oxygen Concentrators
    • 6.3.1.3 Nebulizer Therapy Equipment
    • 6.3.1.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.1.5 Home & Transport Ventilators
  • 6.3.2 Tier 2 (OEM Manufacturers)
    • 6.3.2.1 Sleep Apnea Devices
    • 6.3.2.2 Oxygen Therapy
      • 6.3.2.2.1 Portable Oxygen Concentrators
      • 6.3.2.2.2 Stationary Oxygen Concentrators
    • 6.3.2.3 Nebulizer Therapy Equipment
    • 6.3.2.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.2.5 Home & Transport Ventilators
  • 6.3.3 Tier 3 (Regional Independents)
    • 6.3.3.1 Sleep Apnea Devices
    • 6.3.3.2 Oxygen Therapy
      • 6.3.3.2.1 Portable Oxygen Concentrators
      • 6.3.3.2.2 Stationary Oxygen Concentrators
    • 6.3.3.3 Nebulizer Therapy Equipment
    • 6.3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.3.5 Home & Transport Ventilators
• 6.4 Participant Categorization
• 6.5 Company Market Position Analysis
  • 6.5.1 Tier 1 (National DME Providers)
  • 6.5.2 Tier 2 (OEM Manufacturers)
  • 6.5.1 Tier 3 (Regional Independents)
• 6.6 Exit Strategies of Existing Market Players and Their Impact On Market Competitors
  • 6.6.1 Medical Depot, Inc. Dba Drive Devilbiss Healthcare
    • 6.6.1.1 Medical Depot, Inc. dba Drive DeVilbiss Healthcare's Exit Strategy Aims to Realign the Company with its Mission and Vision
    • 6.6.1.2 Entry of React Health following Medical Depot, Inc. dba Drive DeVilbiss Healthcare's exit and its anticipated impact
  • 6.6.2 Philips Respironics
    • 6.6.2.1 Philips Respironics Exit Strategy Stems from Regulatory Pressure, Reputational Impact, And Portfolio Realignment
  • 6.6.3 Fisher & Paykel Healthcare
    • 6.6.3.1 Exit Strategy of Fisher & Paykel Healthcare for F&P Sleep Style CPAP in the U.S.
  • 6.6.4 Invacare
    • 6.6.4.1 Invacare's Exit Strategy Aims to Realign the Company with Its Mission and Vision.
    • 6.6.4.2 Entry of React Health Following Invacare's Exit and Its Anticipated Impact
  • 6.6.5 Resmed
    • 6.6.5.1 ResMed's Exit Strategy from the Portable Oxygen Concentrator (POC) Market
  • 6.6.6 Medtronic
    • 6.6.6.1 Medtronic Exit Strategy
  • 6.6.7 Teleflex Incorporated
    • 6.6.7.1 Teleflex Incorporated Exit Strategy
  • 6.6.8 Breas Medical AB
    • 6.6.8.1 Breas Medical - Exit Strategy for Z1 & Z2 Series CPAP Devices
• 6.7 Strategy Mapping
  • 6.7.1 Tier 1 (National DME Providers)
    • 6.7.1.1 Mergers and Acquisitions
    • 6.7.1.2 Collaborations & Partnerships
  • 6.7.2 Tier 2 (OEM Manufacturers)
    • 6.7.2.1 New Product Launch
    • 6.7.2.2 Mergers and Acquisitions
    • 6.7.2.3 Other Strategies
  • 6.7.3 Tier 3 (Regional Independents)
    • 6.7.3.1 Mergers and Acquisitions
• 6.8 List of Other Market Players